Introduction
============

Lead placement and obtaining adequate sensing parameters in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients during implantable cardioverter defibrillator (ICD) implantation can be troublesome and difficult due to extensive fibro-fatty replacement of the right ventricular myocardium. In selected cases, the pace-sense lead can be placed in the left ventricle (LV) through the coronary sinus during the same procedure avoiding repeated procedures such as subcutaneous ICD or epicardial lead placement. The purpose of this report is to show a possible solution when sensing problems are encountered during an ICD implantation in a patient with ARVC. In such a patient, due to inadequate sensing parameters in the right ventricle, we decided to place the pace/sense lead in the coronary sinus.

Case Report
===========

A 64-year-old female patient with ARVC was referred to our center for ICD implantation. She presented with occasional episodes of dyspnea, weakness, syncope and non-sustained ventricular tachycardia (NSVT) on Holter electrocardiogram (ECG). She also had an episode of sustained monomorphic VT which was successfully cardioverted to sinus rhythm. She had a family history of sudden cardiac death. ECG showed sinus rhythm with right bundle branch block, inverted T waves in the precordial leads and visible epsilon wave. Echocardiography showed enlargement of the right ventricle (RVOT 40 mm), hypokinetic and dyskinetic apical and lateral wall, and reduction of the systolic longitudinal function of the right ventricle (RV) ([Fig. 1](#f1){ref-type="fig"}). Coronary angiography was normal.

![Echocardiographic image: enlargement of the right ventricle; hypokinetic and dyskinetic apical and lateral wall shown over the echocardiographic parasternal long axis (PLAX) view.](acc-58-391-f1){#f1}

With four major and two minor criteria fulfilled, ARVD was diagnosed ([@r1]). She was scheduled for ICD implantation for secondary sudden cardiac death prevention. We introduced a dual coil, active fixation ICD lead through the axillary vein (Medtronic Sprint Quattro Secure, 6947-65, DF-1/IS-1, Minneapolis, USA). More than 20 positions were changed in the RV (high, mid and apical septum, infero-basal, apical and lateral wall) and even right ventricular outflow tract (anterior and septal). However, maximum R wave amplitude was 2 mV with pacing threshold of 0.5V with pulse weight 0.40 ms.

Due to inappropriate sensing in several RV segments, at the time of the procedure we decided to place the LV epicardial lead through the coronary sinus as pace/sense lead of the ICD system. The LV lead (Biotronik Sentus ProMRI L85, IS-1, Berlin, Germany) was placed in the basal part of the lateral vein ([Fig. 2](#f2){ref-type="fig"}). The pacing threshold was 1.0V/0.40 ms and R wave was 9 mV. ICD lead was placed in the RV apex. LV lead was then connected to the ICD sense-pace port and the high voltage coils of the RV lead were connected in the usual way. The RV sense-pace lead was capped off. The device sensed an R wave of 7.0 mV after the procedure and 48 hours later.

![Chest x-ray after implantable cardioverter defibrillator (ICD) system implantation (anterior/posterior projection, AP) with left ventricle (LV) lead visible.](acc-58-391-f2){#f2}

Discussion
==========

Arrhythmogenic right ventricular cardiomyopathy is a hereditary disease characterized by fibro-fatty replacement of myocardium, occurrence of ventricular arrhythmias and risk of sudden cardiac death ([@r2]). ICD implantation is indicated in selected patients ([@r3], [@r4]). Achieving stable lead position with adequate sensing can be challenging. We present a case of effective solution of the ICD lead sensing problem during the implant procedure by placing the LV epicardial lead as ICD pace-sense lead. Decision to use DF-1/IS-1 connector ICD and compatible lead was made based on the previously described possible difficulties to ensure adequate sensing or pacing parameters in the RV in patients with ARVD. We were aware of possible limitations in this type of connector, but it gives us freedom to use another pace/sense lead in cases like this. Although there are other options such as placing the epicardial ICD system or possibly subcutaneous ICD, this would usually have to involve another invasive procedure. With our approach, there are concerns regarding the LV lead dislodgement, however, it has been previously described ([@r5], [@r6]). In the previous cases described by Niazi *et al*. ([@r5]) and Lochy *et al*. ([@r6]), this approach was anticipated based on the voltage maps or previous pace/sense problems and the LV lead placement was planned before.

We can conclude that the difficulties in ICD lead positioning in ARVC patients can be safely overcome by placing the epicardial pace/sense LV lead.
